Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

UK Market Access

This page shows the latest UK Market Access news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC

NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC

Fleur Chandler, head of market access, Sanofi UK and Ireland, commented: “We’re thrilled to have worked closely with NICE and NHS England to reach this point whereby cemiplimab has transitioned ... We look forward to continuing discussions with other

Latest news

More from news
Approximately 41 fully matching, plus 45 partially matching documents found.

Latest Intelligence

  • Are smart deals a clever solution to UK market access? Are smart deals a clever solution to UK market access?

    A perfect environment for innovative market access. It is important to first acknowledge the extent to which the UK market access environment has transformed – and why it is now ideal for ... Fourteen years later, the UK is now leading the way in

  • Entrepreneurial Winning Women Entrepreneurial Winning Women

    Additionally, the programme offers access to vast resources and rich networks strengthening the ability of female entrepreneurs to become market leaders. ... These women have the potential to be a powerful economic force, paving the way for a greater

  • The Orkambi row explained The Orkambi row explained

    Is the UK an extreme outlier in terms of market access for Orkambi? ... The long stalemate certainly puts the UK far behind many comparable countries regarding Orkambi access.

  • #OrkambiNow? #OrkambiNow?

    This would represent a transition towards an outcomes-based reimbursement system, which is certain to be central to market access for many novel drugs in the future. ... For people with CF and these rare conditions, this vision of a less adversarial and

  • The UK’s new five-year pricing agreement The UK’s new five-year pricing agreement

    Nevertheless, it provides some stability and predictability for the UK sector, where the uncertainties of Brexit continue to threaten the overall attractiveness of the UK market. ... Mike Thompson, chief executive, ABPI. Having agreed a ceiling on growth,

More from intelligence
Approximately 5 fully matching, plus 19 partially matching documents found.

Latest appointments

  • RJW & Partners appoints new director RJW & Partners appoints new director

    She joins the firm from pharma service provider ICON, where she served as principal and head of EU pricing and market access. ... Prior to that Beecher was with  Bristol-Myers Squibb, where she was UK pricing and market access manager, and before that

  • PM Society appoints new chairman PM Society appoints new chairman

    Bradley previously served as the PM Society's market access lead, and is brand manager for Shire's internal medicine business unit, making him the society's first chair from a ... He has since held a series of increasingly senior positions at Shire,

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... He also brings experience form Boehringer Ingelheim, where he

  • GalbraithWight appoints Eithne McShane and Steve Mazzarese GalbraithWight appoints Eithne McShane and Steve Mazzarese

    McShane (pictured right) brings experience to the role from Bayer, where she served as market access manager, Novartis Oncology and Therabel Europe. ... In her new role at UK-based market access consultancy she will be tasked with growing

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    Will take up commercial role at UK pharma bodyat the end of the month. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Market Access Transformation (MAT) Secures First Institutional Funding Led by Silversmith Capital Partners

    SHORT HILLS, NJ – December 2, 2020 – Market Access Transformation (MAT), a global healthcare company that uses cutting edge technology to automate and modernize how life sciences companies capture mission-critical insights ... About Market Access

  • Adelphi Research UK wins Agency of the Year at BHBIA Conference

    Adelphi Research UK’s MD Rachel Medcalf also received an award for her contribution as Chair of the BHBIA Ethics and Compliance committee. ... Adelphi Research UK is based south Manchester, in Bollington, Cheshire and is part of the Adelphi Group of

  • No Voice, No Choice

    Experts in UK market research, the agency challenges their clients to think differently by pushing the boundaries to help them drive change. ... brand communications and enabling market access.

  • 6 Ways to Make MROC’s Rock

    Adelphi Research UK are experts in GDPR with a dedicated team linked closely with BHBIA who can offer more guidance on any concerns you may have with compliance.

  • 6 Ways to Ensure Payer Research Delivers

    Our Market Access team has reflected on our extensive experience researching a broad range of payer audiences and come up with the following ‘musts’ for ensuring payer research sings. ... Adelphi has a dedicated Market Access consultancy to help you

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story
...
Working together to achieve better patient pathways
Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.
How design can lead improvement within Pharma...

Quick links